Article

Contribution of CCR4 and CCR8 to antigen-specific T(H)2 cell trafficking in allergic pulmonary inflammation

Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
The Journal of allergy and clinical immunology (Impact Factor: 11.25). 01/2009; 123(1):67-73.e3. DOI: 10.1016/j.jaci.2008.09.049
Source: PubMed

ABSTRACT Recruitment of antigen-specific T(H)2 cells into the lung is critical for the development of allergic airway inflammation. Although CCR4 and CCR8 are preferentially expressed on T(H)2 cells and CCR4, CCR8, and CXCR3 ligands are increased in asthma, the specific relative contribution of these receptors to antigen-specific T(H)2 cell trafficking into the allergic lung is not known.
To determine the relative contribution of the chemokine receptors CCR4, CCR8, and CXCR3 to antigen-specific T(H)2 cell trafficking in a murine model of allergic pulmonary inflammation.
We used adoptive transfer experiments to compare the trafficking of wild-type antigen-specific T(H)2 cells with antigen-specific T(H)2 cells deficient in CCR4, CCR8, or CXCR3.
CCR4-deficient antigen-specific T(H)2 cells failed to traffic efficiently into the lung and the airways. In contrast, CCR8-deficient antigen-specific T(H)2 cells accumulated in these sites. Trafficking of CXCR3-deficient antigen-specific T(H)2 cells and CCR4-deficient and CCR8-deficient antigen-specific T(H)1 cells were comparable to their wild-type counterparts. Approximately 60% of IL-4-producing antigen-specific T cells expressed CCR4. Disruption of CCR4-mediated antigen-specific T(H)2 cell trafficking decreased the levels of T(H)2-type cytokines in the airways and reduced airway eosinophilia and mucus production.
Our study demonstrates that CCR4 is required for the efficient entry of antigen-specific T(H)2 cells into the lung and the airways in a murine model of allergic pulmonary inflammation.

0 Followers
 · 
91 Views
  • Source
    • "l outcome by an en - dogenous biased agonist of a chemokine receptor . Data obtained in humans has been corroborated to a certain extent by rodent models of allergic airways disease . Mikhak et al showed that antigen - specific Th2 cells adoptively transferred from CCR4 - deficient mice fail to traffic in significant numbers to the allergic lung ( Mikhak et al . , 2009 ) . Similarly , antibody neutraliza - tion of either CC17 or CCL22 proved to be effective in reducing leukocyte recruitment to the lung and associated parameters of inflammation , following allergen challenge ( Kawasaki et al . , 2001 ; Lloyd et al . , 2000 ) . In contrast to these studies , ovalbumin chal - lenged CCR4 null mice were n"
    [Show abstract] [Hide abstract]
    ABSTRACT: Since their discovery in the early 1990s, the chemokine receptor family of G protein-coupled receptors (GPCRs) has been the source of much pharmacological endeavour. Best known for their key roles in recruiting leukocytes to sites of infection and inflammation, the receptors present themselves as plausible drug targets for therapeutic intervention. In this article, we will focus our attention upon CC Chemokine Receptor Four (CCR4) which has been implicated in diseases as diverse as allergic asthma and lymphoma. We will review the discovery of the receptors and their ligands, their perceived roles in disease and the successful targeting of CCR4 by both small molecule antagonists and monoclonal antibodies. We will also discuss future directions and strategies for drug discovery in this field. Copyright © 2015. Published by Elsevier B.V.
    European journal of pharmacology 05/2015; 101. DOI:10.1016/j.ejphar.2015.05.018 · 2.68 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Since primary photons can provide information concerning the position of radioisotope (RI) accumulation and the energy of the photons, it would seem reasonable to vary the position and width of the energy window depending on the type of RI and the energy resolution of the detector to collect as many of the primary photons as possible. The authors propose a method for determining energy window width and position for scintigraphic imaging to collect as many of the primary photons as possible, and studied the influence on the Triple Energy Window (TEW) scatter compensation method of setting such energy window levels for Tc-99m (single photopeak) and Tl-201 (multiple photopeaks) using detector with different energy resolution through simulation. The Monte Carlo simulations were verified by comparing the regional energy spectrum at the phantom obtained from the simulation against experimental measurements. The energy window with the authors' proposed method for Tc-99m is 20% and 47.3% for Tl-201 using gamma camera, and 9.8% for Tc-99m using a semiconductor detector with a theorized energy resolution of 7.0 keV
    Nuclear Science Symposium, 1997. IEEE; 12/1997
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This review summarizes selected articles appearing in 2008 in the Journal. Articles chosen include those improving our understanding of mechanisms of allergic diseases by focusing on human basophil, mast cell, and eosinophil biology; IgE and its high-affinity receptor on various cells; novel properties of omalizumab; airways remodeling; and genetics. Articles from other journals have been included to supplement the topics presented.
    The Journal of allergy and clinical immunology 04/2009; 123(3):569-74. DOI:10.1016/j.jaci.2009.01.041 · 11.25 Impact Factor
Show more

Preview

Download
0 Downloads
Available from